United States - English - NLM (National Library of Medicine)

genzyme corporation - lapine t-lymphocyte immune globulin (unii: d7rd81he4w) (lapine t-lymphocyte immune globulin - unii:d7rd81he4w) - lapine t-lymphocyte immune globulin 5 mg in 1 ml - thymoglobulin is indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant. thymoglobulin is to be used in conjunction with concomitant immunosuppression. thymoglobulin is contraindicated in patients with history of allergy or anaphylactic reaction to rabbit proteins or to any product excipients, or who have active acute or chronic infections that contraindicate any additional immunosuppression [see warnings and precautions (5.2, 5.5) and adverse reactions (6.2)] . risk summary animal reproduction studies have not been conducted with thymoglobulin. it is also not known whether thymoglobulin can cause fetal harm. thymoglobulin should be given to a pregnant woman only if the benefit outweighs the risk. risk summary thymoglobulin has not been studied in nursing women. it is not known whether this drug is excreted in human milk. because other immunoglobulins are excreted in human milk, breastfeeding should be discontinued during thymoglobulin therapy. contracepti

United States - English - NLM (National Library of Medicine)

hadaf llc - lapine interferon gamma immune globulin 12c, 30c, 50c purpose: enchance magnitude of immune response, lapine histamine immune globulin 12c, 30c, 50c purpose: reduce histamine and inflammation response, lapine cd4 immune globulin 12c, 30c, 50c purpose: enhance functional activity of immune system - homeopathic, enhance magnitude of immune response reduce histamine and inflammation response enhance functional activity of immune system • shorten the duration of flu and cold symptoms • reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat stop use and ask a doctor if symptoms persist or worsen. do not use if known sensitivity to brillia health cold-flu recover y or any of its ingredients exists.

United States - English - NLM (National Library of Medicine)

hadaf llc - lapine bradykinin immune globulin 12c, 30c, 50c purpose reduces frequency and intensity of cough lapine morphine immune globulin 12c, 30c, 50c purpose reduces pain response lapine histamine immune globulin 12c, 30c, 50c purpose.reduces histamine and inflammation response - homeopathic, reduces frequency and intensity of cough reduces pain responselapine histamine immune reduces histamine and inflammation response • suppresses wet and dry cough • reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat • antihistamine and decongestant/anti-inflammatory • reduces sore throat pain stop use and ask a doctor if symptoms persist or worsen. do not use if known sensitivity to brillia health cough control or any of its ingredients exists.

United States - English - NLM (National Library of Medicine)

hadaf llc - lapine s-100 immune globulin (unii: a4fh976kaq) (lapine s-100 immune globulin - unii:a4fh976kaq) - uses - reduce feelings of anxiety, excitability, and stress - reduce feelings of irritability - reduce feelings of irritability - improve concentration of attention - enhance clarity purpose improve emotional regulation, hyperactivity, and attention

United States - English - NLM (National Library of Medicine)

hadaf llc - lapine s-100 immune globulin (unii: a4fh976kaq) (lapine s-100 immune globulin - unii:a4fh976kaq) - uses - reduce feelings of anxiety, restlessness, and stress - reduce feelings of irritability - reduce feelings of impulsivity - improve concentration of attention - enhance clarity purpose improve emotional regulation, focus, and attention

United States - English - NLM (National Library of Medicine)

hadaf llc - lapine interferon gamma immune globulin (unii: q2ks2oi6sa) (lapine interferon gamma immune globulin - unii:q2ks2oi6sa), lapine histamine immune globulin (unii: 7u4t47r0dd) (lapine histamine immune globulin - unii:7u4t47r0dd), lapine cd4 immune globulin (unii: uif41k6wr9) (lapine cd4 immune globulin - unii:uif41k6wr9) -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 20 mg - tablet, orally disintegrating - excipient ingredients: crospovidone; mannitol; colloidal anhydrous silica; microcrystalline cellulose; polacrilin potassium; aspartame; sodium stearylfumarate; flavour - zylapine odt is indicated for the treatment of schizophrenia and related psychoses. zylapine odt alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zylapine odt for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 15 mg - tablet, orally disintegrating - excipient ingredients: mannitol; microcrystalline cellulose; sodium stearylfumarate; colloidal anhydrous silica; crospovidone; aspartame; polacrilin potassium; flavour - zylapine odt is indicated for the treatment of schizophrenia and related psychoses. zylapine odt alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zylapine odt for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; sodium stearylfumarate; polacrilin potassium; aspartame; colloidal anhydrous silica; mannitol; crospovidone; flavour - zylapine odt is indicated for the treatment of schizophrenia and related psychoses. zylapine odt alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zylapine odt for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; polacrilin potassium; aspartame; mannitol; crospovidone; sodium stearylfumarate; colloidal anhydrous silica; flavour - zylapine odt is indicated for the treatment of schizophrenia and related psychoses. zylapine odt alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zylapine odt for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.